R. T. Gansevoort, M. Arici, and T. Benzing, “Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice”, KIDNEYS, no. 3.17, pp. 34–38, Sep. 2021.